Ronald Blum, Ph.D., is an experienced professional currently serving as the Chief Science Officer at Sinai Labs. Throughout their career, Ronald has held various leadership roles in marketing and commercialization in companies like MiraDx, Inc., IncellDx, and OncoTracker. With a Ph.D. in Biophysics from the University of California Berkeley, Ronald is also the CEO of Blum & Associates Consulting, LLC.
May, 2023 - present